Wall Street Thinks This Biotech Stock Could Soar 57%
Biotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
This piece breaks down why Total Market Return 2024 matters, highlighting drivers, risks, and practical steps to align holdings with your goals.
28,491 articlesBiotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
Market rallies can mask drift in your asset mix. Learn why right now is a great moment to rebalance and how to do it ...
S&P Global Market Intelligence forecasts a slow return to pre-crisis fuel flows. Gas prices and pump experiences may ...
The equal-weight S&P 500 outperformed the cap-weighted index this week as investors rotate away from mega cap tech to...
Barstool founder Dave Portnoy tells Fox Business he will hold Bitcoin to zero after buying near $100,000, underscorin...
A defensive utility ETF is gaining attention as AI infrastructure ramps up, potentially making this “boring” ETF one ...
Oil hovers near $70 a barrel as U.S.-Iran tensions flare, signaling a risk premium for energy and a wait-and-see stan...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
Bill Ackman is pursuing a Berkshire Hathaway–style Pershing Square, with Amazon and Meta as core bets. The strategy h...
A trio of XRP ETFs began trading in 2026, offering exposure to XRP without direct coin ownership. This piece reviews ...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...